Evaluation of data quality in the cancer registry: Principles and methods. Part I: Comparability, validity and timeliness

被引:416
作者
Bray, Freddie [1 ,2 ]
Parkin, D. Max [3 ,4 ,5 ]
机构
[1] Canc Registry Norway, Inst Populat Based Canc Res, Dept Clin & Registry Based Res, N-310 Oslo, Norway
[2] Univ Oslo, Inst Basic Med Sci, Dept Biostat, N-0316 Oslo, Norway
[3] Univ Oxford, Clin Trials Serv Unit, Oxford, England
[4] Univ Oxford, Epidemiol Studies Unit, Oxford, England
[5] Canc Res UK, Ctr Epidemiol Math & Stat, London, England
关键词
Cancer registry; Data quality; Comparability; Completeness; Validity; Timeliness; Quality control; BREAST; PROSTATE;
D O I
10.1016/j.ejca.2008.11.032
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The value of the modern cancer registry and its ability to carry out cancer control activities rely heavily on the underlying quality of its data and the quality control procedures in place. This two-part review provides an update of the practical aspects and techniques for addressing data quality at the cancer registry. This first installment of the review examines the factors influencing three of the four key aspects, namely, the comparability, validity and timeliness of cancer registry data. Comparability of cancer data may be established through a comprehensive review of the registration routines in place. Validity is examined via numerical indices of that permit comparisons with other registries, or, within a registry, over time, or with respect to specified subsets of cases. There are no international guidelines for timeliness at present, although specific standards for the abstraction and reporting of registry have been set out by certain organisations. (C) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:747 / 755
页数:9
相关论文
共 39 条
[1]  
*AM COLL SURG, 2006, COMM CANC PROGR STAN
[2]  
[Anonymous], CANC INC SWED 2006
[3]  
[Anonymous], 2013, International Classification of Disease for Oncology
[4]  
[Anonymous], 2002, IARC Scientific Publication
[5]   THE ROLE OF THE CANCER REGISTRY IN CANCER CONTROL [J].
ARMSTRONG, BK .
CANCER CAUSES & CONTROL, 1992, 3 (06) :569-579
[6]   LIMITATIONS OF THE DEATH CERTIFICATE ONLY INDEX AS A MEASURE OF INCOMPLETENESS OF CANCER REGISTRATION [J].
BRENNER, H .
BRITISH JOURNAL OF CANCER, 1995, 72 (02) :506-510
[7]   LATENT CARCINOMA OF PROSTATE AT AUTOPSY IN 7 AREAS - COLLABORATIVE STUDY ORGANIZED BY INTERNATIONAL-AGENCY-FOR-RESEARCH-ON-CANCER, LYONS, FRANCE [J].
BRESLOW, N ;
CHAN, CW ;
DHOM, G ;
DRURY, RAB ;
FRANKS, LM ;
GELLEI, B ;
LEE, YS ;
LUNDBERG, S ;
SPARKE, B ;
STERNBY, NH ;
TULINIUS, H .
INTERNATIONAL JOURNAL OF CANCER, 1977, 20 (05) :680-688
[8]   HOW ACCURATE ARE SCOTTISH CANCER REGISTRATION DATA [J].
BREWSTER, D ;
CRICHTON, J ;
MUIR, C .
BRITISH JOURNAL OF CANCER, 1994, 70 (05) :954-959
[9]  
*CDCP, 1997, FY 1997 COOP AGR GUI
[10]   An application of the two-source capture-recapture method to estimate the completeness of the Tuscany Cancer Registry, Italy [J].
Crocetti, E ;
Miccinesi, G ;
Paci, E ;
Zappa, M .
EUROPEAN JOURNAL OF CANCER PREVENTION, 2001, 10 (05) :417-423